Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Sandoz, a Novartis division, announced  that the Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions recommending the approval of its biosimilars rituximab and  etanercept in Europe, for the same indications as the respective reference medicines.

Sandoz’s Rituximab and Etanercept Biosimilars Recommended for European Approval

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Although technical paths for continuous solid-dosage manufacturing have been laid out and equipment and control systems have been developed, industry is slow to move forward.

Paving the Way for Continuous Manufacturing

The funding allows the company to broaden its range of services and finance its move to new laboratory facilities in the Illkirch-Graffenstaden innovation park in northeast France.

Inoviem Scientific Secures Funding to Finance Expansion

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Pharmaceutical Technology spoke with CPhI North America presenter Jonathan Helfgott to discuss navigating GDUFA and helpful tips for submitting successful ANDAs.

Former CDER OSI Associate Director for Risk Science to Speak at CPhI North America 2017

The project will foster the translation of nanomedicine applications for the treatment of cardiovascular diseases.

Nemera Joins European Project to Develop Inhaled Nanoparticles for Heart Disease

The agency issued its recommendation for the influenza virus strains European vaccine manufacturers should include for 2017.

EMA Updates Flu Vaccination Recommendations

In a new study, researchers from Boston Children’s Hospital study responses to pneumococcal vaccine in infant monkeys.

Researchers Study Vaccine Responses in Newborns

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Researchers continue efforts to overcome challenges of effective oral delivery of biologic drugs.

Seeking Solutions for Oral Delivery of Biologic APIs

GW Pharmaceuticals plans to submit a regulatory filing to FDA and EMA following two positive Phase III trials of Epidiolex in patients with Lennox-Gastaut Syndrome.